Medicinal Mushroom Extract Market is Projected to Grow at a CAGR of 6.40% During the Forecast Period due to Health Benefits Associated with Medicinal Mushrooms

Global Medicinal Mushroom Extract Market is predicted to reach USD 19.05027063 Billion at a CAGR of 6.40% during the forecast period:

Market Research Future (MRFR) has published a cooked research report on the “Global Medicinal Mushroom Extract Market” that contains information from 2018 to 2032. The Global Medicinal Mushroom Extract Market is estimated to register a CAGR of 6.40% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the Global Medicinal Mushroom Extract Market — Bio Botanica, Inc. (US), New Roots Herbal, Inc. (Canada), Nature's Way Products, LLC (US), Aloha Medicinals (US), The Nature's Bounty Co. (US), Biofinest (US), Real Mushrooms (Canada), Oriveda BV (Netherlands), Nyishar (UK), and Sayan Chaga (US).

Market Highlights

The Global Medicinal Mushroom Extract Market is accounted to register a CAGR of 6.40% during the forecast period and is estimated to reach USD 19.05027063 Billion by 2032.

The global medicinal mushroom extract market has been experiencing significant growth over the past few years. Medicinal mushrooms are fungi that have been traditionally used in various cultures for their therapeutic properties. These mushrooms contain bioactive compounds, such as polysaccharides, triterpenoids, and phenolic compounds, which are believed to have numerous health benefits.

Segment Analysis

The Global Medicinal Mushroom Extract Market has been segmented based Type, Function, and Form.

Based on type, the Medicinal Mushroom Extract market segmentation includes chaga, reishi, shiitake, cordyceps, maitake, turkey tail, and others. The shiitake segment dominated the market; Shiitake mushrooms have gained popularity for their various health benefits and medicinal properties. They contain bioactive compounds like polysaccharides, beta-glucans, and other nutrients believed to have immune-boosting, anti-inflammatory, and antioxidant effects. Shiitake mushrooms are also known for their potential anticancer properties and have been used in traditional medicine for centuries. The widespread use and recognition of Shiitake mushrooms in traditional Asian medicine and their increasing demand in the market.

Based on function, the Medicinal Mushroom Extract market segmentation includes skin care, antioxidant, immunity enhancer, and others. The antioxidants segment occupies the largest share ly due to its ability to protect against genetic mutation and cellular damage. The antioxidant segment is likely to record significant growth during the forecast year. The ability of antioxidants to protect human cells against free radicals that can cause diseases like cancer, heart issues, and others is a prominent reason for the expected growth.

Based on the Form, the Medicinal Mushroom Extract market segmentation includes capsules & tablets, liquid, and powder. The capsules & tablets segment dominates the market owing to its easy and wide availability due to its advantages, such as extended shelf life and convenient usage. These forms of packaging offer the benefit of preserving the product for a longer period, ensuring its effectiveness and quality. Additionally, capsules and tablets provide convenience to consumers, allowing them to easily incorporate these products into their daily routines.

Regional Analysis

The Global Medicinal Mushroom Extract Market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America, Europe, Asia-Pacific, and Rest of the World. The North American medicinal mushroom extract market will dominate this market, attributed to a rise in the popularity of these mushrooms as superfoods in this Region. Further, the major countries studiedin the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Europe's Medicinal Mushroom Extract market accounts for the second-largest market share. The industry's growth in the Region is driven by a heightened consumer consciousness regarding the importance of maintaining overall health and well-being. Further, the German Medicinal Mushroom Extract market held the largest market share, and the UK Medicinal Mushroom Extract market was the fastest-growing market in the European Region.

The Asia-Pacific Medicinal Mushroom Extract Market is expected to grow fastest from 2023 to 2032. The increased demand for functional mushrooms in the Region is driven by their popularity as functional foods and potential health benefits. These mushrooms are sought after in the food and beverage industry due to their nutritional value and are increasingly being incorporated into regular diets as a healthy food choice. As consumers become more conscious of the importance of a nutritious diet, the demand for functional mushrooms continues to rise. This trend is supported by the recognition of these mushrooms as valuable ingredients that can enhance the nutritional profile of various food and beverage products. Moreover, China’s Medicinal Mushroom Extract market held the largest market share, and the Indian Medicinal Mushroom Extract market was the fastest-growing market in the Asia-Pacific region.

Key Findings of the Study

• The Global Medicinal Mushroom Extract Market is expected to reach USD 19.05027063 Billion by 2032 at a CAGR of 6.40% during the forecast period.


• Europe's Medicinal Mushroom Extract market accounts for the second-largest market share. The industry's growth in the Region is driven by a heightened consumer consciousness regarding the importance of maintaining overall health and well-being.


• Based on type, the Medicinal Mushroom Extract market segmentation includes chaga, reishi, shiitake, cordyceps, maitake, turkey tail, and others.


• Bio Botanica, Inc. (US), New Roots Herbal, Inc. (Canada), Nature's Way Products, LLC (US), Aloha Medicinals (US), The Nature's Bounty Co. (US), Biofinest (US), Real Mushrooms (Canada), Oriveda BV (Netherlands), Nyishar (UK), and Sayan Chaga (US)